Search Results - "Nielsen, Elsebet Ø"

Refine Results
  1. 1

    Crystal structure of Lymnaea stagnalis AChBP complexed with the potent nAChR antagonist DHβE suggests a unique mode of antagonism by Shahsavar, Azadeh, Kastrup, Jette S, Nielsen, Elsebet Ø, Kristensen, Jesper L, Gajhede, Michael, Balle, Thomas

    Published in PloS one (22-08-2012)
    “…Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand-gated ion channels that belong to the Cys-loop receptor superfamily. These receptors are…”
    Get full text
    Journal Article
  2. 2
  3. 3

    GABA(A) receptor α subunits differentially contribute to diazepam tolerance after chronic treatment by Vinkers, Christiaan H, van Oorschot, Ruud, Nielsen, Elsebet Ø, Cook, James M, Hansen, Henrik H, Groenink, Lucianne, Olivier, Berend, Mirza, Naheed R

    Published in PloS one (2012)
    “…Within the GABA(A)-receptor field, two important questions are what molecular mechanisms underlie benzodiazepine tolerance, and whether tolerance can be…”
    Get full text
    Journal Article
  4. 4

    The rapid hydrolysis of chlordiazepoxide to demoxepam may affect the outcome of chronic osmotic minipump studies by Vinkers, Christiaan H., Korte-Bouws, Gerdien A. H., Sastre Toraño, Javier, Mirza, Naheed R., Nielsen, Elsebet Ø., Ahring, Philip K., de Jong, Gerhardus J., Olivier, Berend

    Published in Psychopharmacologia (01-03-2010)
    “…Background In chronic studies, the classical benzodiazepine chlordiazepoxide (CDP) is often the preferred drug because, unlike other benzodiazepines, it is…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    GABAA Receptor α Subunits Differentially Contribute to Diazepam Tolerance after Chronic Treatment by Vinkers, Christiaan H., van Oorschot, Ruud, Nielsen, Elsebet Ø., Cook, James M., Hansen, Henrik H., Groenink, Lucianne, Olivier, Berend, Mirza, Naheed R.

    Published in PloS one (13-08-2012)
    “…Background Within the GABAA-receptor field, two important questions are what molecular mechanisms underlie benzodiazepine tolerance, and whether tolerance can…”
    Get full text
    Journal Article
  8. 8
  9. 9

    A combined α7 nicotinic acetylcholine receptor agonist and monoamine reuptake inhibitor, NS9775, represents a novel profile with potential benefits in emotional and cognitive disturbances by Andreasen, Jesper T., Redrobe, John P., Nielsen, Elsebet Ø., Christensen, Jeppe K., Olsen, Gunnar M., Peters, Dan

    Published in Neuropharmacology (01-10-2013)
    “…As affective and cognitive disturbances frequently co-occur in psychiatric disorders, research into opportunities to simultaneously target both entities is…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Chronic oral nicotine increases brain [3H]epibatidine binding and responsiveness to antidepressant drugs, but not nicotine, in the mouse forced swim test by Andreasen, Jesper T., Nielsen, Elsebet Ø., Redrobe, John P.

    Published in Psychopharmacologia (01-08-2009)
    “…Introduction Smoking rates among depressed individuals is higher than among healthy subjects, and nicotine alleviates depressive symptoms. Nicotine increases…”
    Get full text
    Journal Article
  13. 13

    Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan by Jacobsen, Jacob P. R., Nielsen, Elsebet Ø., Hummel, Rene, Redrobe, John Paul, Mirza, Naheed, Weikop, Pia

    Published in Psychopharmacologia (01-08-2008)
    “…Rationale Exploring differences between mouse strains in drug effects in models of antidepressant-like activity may provide clues to the neurobiology of…”
    Get full text
    Journal Article
  14. 14

    Delineation of an endogenous zinc-binding site in the human dopamine transporter by Norregaard, Lene, Frederiksen, Dorte, Nielsen, Elsebet Ø., Gether, Ulrik

    Published in The EMBO journal (03-08-1998)
    “…The molecular basis for substrate translocation in the Na+/Cl−‐dependent neurotransmitter transporters remains elusive. Here we report novel insight into the…”
    Get full text
    Journal Article
  15. 15

    Bioisosteric Modifications of 2-Arylureidobenzoic Acids:  Selective Noncompetitive Antagonists for the Homomeric Kainate Receptor Subtype GluR5 by Valgeirsson, Jon, Nielsen, Elsebet Ø, Peters, Dan, Mathiesen, Claus, Kristensen, Anders S, Madsen, Ulf

    Published in Journal of medicinal chemistry (30-12-2004)
    “…2-Arylureidobenzoic acids (AUBAs) have recently been presented as the first series of selective noncompetitive GluR5 antagonists. In this paper we have…”
    Get full text
    Journal Article
  16. 16

    The nicotinic α7 acetylcholine receptor agonist ssr180711 is unable to activate limbic neurons in mice overexpressing human amyloid-β1–42 by Søderman, Andreas, Thomsen, Morten S, Hansen, Henrik H, Nielsen, Elsebet Ø, Jensen, Morten S, West, Mark J, Mikkelsen, Jens D

    Published in Brain research (28-08-2008)
    “…Abstract Recent studies have demonstrated that amyloid-β1–42 (Aβ1–42 ) binds to the nicotinergic α7 acetylcholine receptor (α7 nAChR) and that the application…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    [11 C]NS8880, a promising PET radiotracer targeting the norepinephrine transporter by Vase, Karina H, Peters, Dan, Nielsen, Elsebet Ø, Alstrup, Aage K.O, Bender, Dirk

    Published in Nuclear medicine and biology (01-10-2014)
    “…Abstract Introduction Positron emission tomography (PET) imaging of the norepinephrine transporter (NET) is still hindered by the availability of useful PET…”
    Get full text
    Journal Article
  20. 20

    The dopaminergic stabilizers pridopidine (ACR16) and (−)-OSU6162 display dopamine D 2 receptor antagonism and fast receptor dissociation properties by Dyhring, Tino, Nielsen, Elsebet Ø., Sonesson, Clas, Pettersson, Fredrik, Karlsson, Jonas, Svensson, Peder, Christophersen, Palle, Waters, Nicholas

    Published in European journal of pharmacology (25-02-2010)
    “…A new pharmacological class of CNS ligands with the unique ability to stimulate or suppress motor and behavioral symptoms depending on the prevailing…”
    Get full text
    Journal Article